Where is the difficulty for the pharmaceutical industry in 2019? Resignation of executives of famous pharmaceutical companies
-
Last Update: 2019-12-24
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
(2019 / 12 / 24) what's the difficulty for China's pharmaceutical industry in 2019? ; four kinds of drugs are facing fierce "containment" due to the outbreak of biological similar drugs; the latest review of nature: targeting cancer stem cells, setting off the upsurge of research and development of anti-cancer drugs; some of the original research drugs are injured after 4 + 7 of the top five drugs; the annual inventory of executives of well-known pharmaceutical companies leaves Be strict This year can be said to be the first year of biological similar drugs in China Another upsurge The competition for rare diseases is becoming increasingly fierce My head hurts More favor the original research medicine and chronic disease medicine Admitting difficulties is not a sign of frustration.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
